SCHEMBL30512977

SCHEMBL30512977

CC1(C)Cc2cc(Br)ccc2C(=O)N1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.58
TDP2 O95551 3/20 0.54
HPGD P15428 3/20 0.51
HSD17B10 Q99714 2/20 0.51
GFER P55789 1/20 0.51
PARP10 Q53GL7 2/20 0.50
PARP11 Q9NR21 1/20 0.50
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
NCOA1 Q15788 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NCOA3 Q9Y6Q9 1/20 0.44
BRD4 O60885 1/20 0.41
CDC7 O00311 1/20 0.40
METAP1 P53582 1/20 0.40
PGR P06401 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22782798 0.80 HTT (0.58) HTTTDP2HPGDHSD17B10GFER
SCHEMBL21768055 0.80 HTT (0.58) HTTHPGDHSD17B10GFERALDH1A1
SCHEMBL21768027 0.78 HTT (0.55) HTTTDP2HPGDHSD17B10GFER
SCHEMBL12302510 0.77 TDP2 (0.48) HTTTDP2PARP10PARP11BRD4
SCHEMBL31394401 0.77 BRD4 (0.46) HTTTDP2HPGDHSD17B10GFER
SCHEMBL4842012 0.75 NPSR1 (0.62) HTTTDP2HPGDHSD17B10GFER
SCHEMBL29964356 0.75 NPSR1 (0.62) HTTTDP2HPGDHSD17B10GFER
SCHEMBL30016582 0.74 TDP2 (0.48) HTTTDP2PARP10PARP11ALDH1A1
SCHEMBL1500161 0.74 TDP2 (0.46) TDP2PARP10PARP11ALDH1A1BRD4
SCHEMBL24697708 0.73 MGAT2 (0.44) HTTTDP2HPGDHSD17B10GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023138612-A1 HETEROCYCLIC COMPOUNDS USEFUL AS HPK1 INHIBITORS SILEXON AI TECHNOLOGY CO., LTD. (CN) 2023-07-27 WO disclosed